PCL Signs Supply Contract for COVID-19 Rapid Test Kits with LG Chem

[Asia Economy Reporter Lee Chun-hee] PCL announced on the 23rd that it has signed a supply contract for professional-use COVID-19 rapid antigen test kits with LG Chem and will begin full-scale domestic supply.

Accordingly, PCL will supply domestically under the name 'PCL COVID-19 Ag Gold,' while LG Chem will supply under its own brand name 'Advansure.' PCL plans to contribute to the stable supply of rapid diagnostic kits in Korea through both direct sales and stable supply via LG Chem.

'PCL's COVID-19 Ag Gold' is a nasopharyngeal-based rapid diagnostic product that can provide results for COVID-19 and various variants within 10 minutes. Going forward, PCL plans to release kits that improve specimen collection convenience based on global clinical results of saliva-based tests. According to clinical results conducted at the Royal College of Medicine of Morocco, the detection rate of the Omicron variant in saliva was more than three times higher compared to nasal samples. PCL has already received approval for saliva-based rapid diagnostic kits in European regions such as Germany and Austria last year.

Kim So-yeon, CEO of PCL, said, "As the rapid increase in confirmed cases is expected to continue, we will actively cooperate with LG Chem to contribute to overcoming COVID-19," adding, "We will stably supply PCL's convenient and differentiated rapid diagnostic kits to nationwide screening clinics, temporary screening centers, and designated medical institutions."

This content was produced with the assistance of AI translation services.